NFSG
EW icon

Newbridge Financial Services Group’s Edwards Lifesciences EW Stock Holding History

Newbridge Financial Services Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.42K Hold
71
– – ﹤0.01% 924
2026
Q1 		$5.69K Hold
71
– – ﹤0.01% 895
2025
Q4 		$6.05K Hold
71
– – ﹤0.01% 869
2025
Q3 		$5.52K Sell
71
-35
-33% -$2.73K ﹤0.01% 1005
2025
Q2 		$8.29K Sell
106
-100
-49% -$7.46K ﹤0.01% 932
2025
Q1 		$14.9K Hold
206
– – ﹤0.01% 606
2024
Q4 		$15.3K Buy
+206
New +$14.4K ﹤0.01% 661
2024
Q3 		– Sell
-135
Closed -$12.5K – 782
2024
Q2 		$12.5K Sell
135
-274
-67% -$24.3K ﹤0.01% 666
2024
Q1 		$39.1K Sell
409
-1,968
-83% -$165K 0.02% 444
2023
Q4 		$181K Sell
2,377
-136
-5% -$9.46K 0.09% 201
2023
Q3 		$174K Buy
2,513
+35
+1% +$2.81K 0.09% 203
2023
Q2 		$234K Buy
2,478
+13
+0.5% +$1.13K 0.11% 183
2023
Q1 		$204K Sell
2,465
-14
-0.6% -$1.1K 0.11% 184
2022
Q4 		$185K Buy
2,479
+27
+1% +$2.08K 0.11% 189
2022
Q3 		$203K Sell
2,452
-16
-0.6% -$1.54K 0.12% 185
2022
Q2 		$235K Buy
2,468
+132
+6% +$13.7K 0.15% 145
2022
Q1 		$275K Buy
2,336
+64
+3% +$7.18K 0.14% 146
2021
Q4 		$294K Buy
2,272
+2,070
+1,025% +$241K 0.14% 152
2021
Q3 		$23K Sell
202
-60
-23% -$6.85K 0.01% 620
2021
Q2 		$27K Sell
262
-50
-16% -$4.71K 0.02% 682
2021
Q1 		$26K Sell
312
-120
-28% -$10.1K 0.02% 613
2020
Q4 		$39K Sell
432
-300
-41% -$24.9K 0.03% 386
2020
Q3 		$58K Buy
+732
New +$57.1K 0.06% 292

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Newbridge Financial Services Group's EW Position: Q2 2026 in Review

Newbridge Financial Services Group held its Edwards Lifesciences (EW) position steady in Q2 2026 at 71 shares worth $6.42K. The position accounts for ﹤0.01% of the portfolio, ranked #924.

Newbridge Financial Services Group first reported a position in EW in Q3 2020 and has held it in 23 quarters since. The position peaked at $294K in Q4 2021. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Newbridge Financial Services Group held 71 shares of Edwards Lifesciences worth $6.42K as of Q2 2026.
  • Newbridge Financial Services Group left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up ﹤0.01% of Newbridge Financial Services Group's portfolio in Q2 2026, its #924 holding.
  • Newbridge Financial Services Group first reported a position in Edwards Lifesciences in Q3 2020 and has held it in 23 quarters since.
  • Newbridge Financial Services Group's Edwards Lifesciences position peaked at $294K in Q4 2021.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Newbridge Financial Services Group's 13F filing for Q2 2026, filed 14 Aug 2026.